Rentschler Commissions 2000-L Single-Use Bioreactor

News
Article

Rentschler Biotechnologie launches 2000-L single-use bioreactor and announces additional expansion.

 

Rentschler Biotechnologie, a contract manufacturing and development organization for biopharmaceuticals, announced on March 23 that the company’s 2000-L single-use bioreactor has been put into operation.

The bioreactor, built and commissioned in six months, doubles the company’s single-use manufacturing capabilities and integrates in the existing manufacturing suites by supplementing two existing 1000-L single-use bioreactors, according to a company statement.

Rentschler has more than five years’ experience with single-use bioreactors and features a facility with a flexible space concept and movable equipment.

Rentschler also announced that the company will invest €24 million to build a system with two 3,000-L stainless steel bioreactors.

Source: Rentschler Biotechnologie

 

Recent Videos
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Behind the Headlines, Episode 18
Drug Digest: Patient Preference Drives Solid Dosage Trends
Related Content